"The Atlantic" noted that the vaccine still protected against other strains such as the H1N1 and B virus, and did provide at least some immunity to H3N2.In January 2018, "The Atlantic" also noted that the severity of the flu season in the United States may have been increased by a shortage of IV bags in hospitals.